Por: CBS News Business May 04, 2023
Novo Nordisk is holding back low doses of Wegovy, its recently approved obesity medication, in the U.S. to conserve supplies for patients already using the drug, the company Thursday.The Danish drugmaker is supplying limited quantities of 0.25 mg, 0.5 mg and 1 mg dose strengths to wholesalers for distribution to retail pharmacies, according to the statement. The holdback is a move to ensure existing patients have continuity of care amid the... + full article
New York Post USA Business July 10, 2023
European drug-safety regulators are probing popular weight-loss drug Ozempic after patients reported that the medicine triggered thoughts of suicide and self harm. The European Medicines Agency (EMA) on Monday that a safety committee was probing Novo Nordisk-made weight-loss... + más
Does Medicare cover Ozempic? | WGN-TV
What is Ozempic? Why stars risk ‘old face’ for trendy weight-loss drug | New York Post
Fox Business USA Business July 10, 2023
Fox News medical contributor Dr. Nicole Saphier discusses the dangers of using the diabetes drug Ozempic for weight loss on 'The Big Money Show.' are looking into possible adverse effects of certain popular weight loss drugs such as Novo Nordisk's Ozempic and... + más
Ozempic, weight-loss drugs probed over reports of suicidal thoughts | Los Angeles Times
Ozempic faces review over concerns it may trigger suicidal thoughts | New York Post
Fox Business USA Business May 04, 2023
Fox News medical contributor Dr. Nicole Saphier discusses the dangers of using the diabetes drug Ozempic for weight loss on 'The Big Money Show.' is cutting U.S. supply on certain dose strengths of its highly sought-after weight loss drug Wegovy due to strong demand. ... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
Wegovy, Ozempic: The barriers to accessing these weight loss drugs | Fox Business
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
CNBC USA Health March 14, 2023
In this articleNovo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019.Alex Flynn Bloomberg Getty Images on Tuesday announced plans to slash the price of several insulin drugs by up to 75% in... + más
Fox Business USA Business March 08, 2023
Fox News medical contributor Dr. Nicole Saphier discusses the dangers of using the diabetes drug Ozempic for weight loss on 'The Big Money Show.' There are a handful of barriers that may prevent patients from being able to attain Wegovy and Ozempic including elevated... + más
Hollywood Ozempic ‘craze’ triggering ‘frustrating’ drug shortages for diabetics | New York Post
Fox Business USA Business January 03, 2023
Fox News contributor Dr. Marc Siegel discusses how the baby formula shortage is impacting families and provides insight into the weight loss drug trial. Novo Nordisk, the maker of weight loss drug Wegovy, said the medication that faced a nationwide shortage due to a rise in... + más
Elon Musk jumps on new weight-loss trend: diabetic medications | Fox Business
Diabetes-related weight loss drugs facing supply issues amid viral trend | Fox Business
About iurex | Privacy Policy | Disclaimer |